BackPelthos Therapeutics Overview

Pelthos Therapeutics Current Cash

Pelthos Therapeutics's current cash is $32M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$31.98M
↑ 24250.24% YoYΔ $31.84M vs prior year quarter

Peer average / median

Loading

Pelthos Therapeutics Current Cash History

Loading

Pelthos Therapeutics vs. peers: Current Cash Comparison

Loading

Pelthos Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Pelthos Therapeutics (PTHS) FAQ

As of the most recent data (March 2026), PTHS shows a current cash of $32M. That compares with $130K in the prior-year period — up 24250.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PTHS's current cash is now $32M (was $130K) — a 24250.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pelthos Therapeutics is outperforming or lagging.

Tracking PTHS's current cash over time shows whether Pelthos Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $32M That compares with $130K in the prior-year period — up 24250.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Pelthos Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $32M) with ownership activity and broader fundamentals.